ID
33209
Descripción
Study ID: 107434 Clinical Study ID: NAP107434 Study Title: A randomised, double-blind, double-dummy, placebo controlled, three-way cross-over study to investigate the effect of single oral doses of 100 mg GW273225 (4030W92) and 325 mg LAMICTAL on resting motor threshold in healthy subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Study Link: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GW273225 Trade Name: lamictal Study Indication: Bipolar Disorder This form contains information about the subjects concomitant medication. It should be filled out at the screening visit. Screening Visit: 28 days prior to first dosing. Treatment Period: The day before dosing, until 48h after dosing. Follow-Up: 14-21 days after last dose
Palabras clave
Versiones (4)
- 1/12/18 1/12/18 -
- 9/12/18 9/12/18 -
- 21/1/19 21/1/19 -
- 25/1/19 25/1/19 - Sarah Riepenhausen
Titular de derechos de autor
GlaxoSmithKline
Subido en
1 de diciembre de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Effect of Lamictal on Resting Motor Threshold
Concomitant Medication
- StudyEvent: ODM
Descripción
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Descripción
Prescribed or Non-Prescribed Medication, including Vitamins, Herbal Remedies and Antacids
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0332185
- UMLS CUI [1,2]
- C3166216
- UMLS CUI [2,1]
- C0332185
- UMLS CUI [2,2]
- C0013231
- UMLS CUI [3,1]
- C0332257
- UMLS CUI [3,2]
- C0042890
- UMLS CUI [4,1]
- C0332257
- UMLS CUI [4,2]
- C1360419
- UMLS CUI [5,1]
- C0332257
- UMLS CUI [5,2]
- C0003138
Descripción
Concomitant Medication Details
Alias
- UMLS CUI-1
- C2347852
Descripción
Start Date
Tipo de datos
date
Alias
- UMLS CUI [1]
- C0808070
Descripción
If known
Tipo de datos
datetime
Alias
- UMLS CUI [1]
- C1301880
Descripción
Generic/Brand
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013227
Descripción
Dose
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3174092
Descripción
Units
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1519795
Descripción
Route
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0013153
Descripción
Frequency
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3476109
Descripción
Indication
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3146298
Descripción
Medication Ongoing
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C2826666
Descripción
Conclusion
Alias
- UMLS CUI-1
- C1707478
Similar models
Concomitant Medication
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C3166216 (UMLS CUI [1,2])
C0332185 (UMLS CUI [2,1])
C0013231 (UMLS CUI [2,2])
C0332257 (UMLS CUI [3,1])
C0042890 (UMLS CUI [3,2])
C0332257 (UMLS CUI [4,1])
C1360419 (UMLS CUI [4,2])
C0332257 (UMLS CUI [5,1])
C0003138 (UMLS CUI [5,2])
C1552089 (UMLS CUI [1,2])
Sin comentarios